Above-Knee-High Application of Lower Limb Compression and Its Impact on Clinical Outcome in Patients Hospitalized With Heart Failure Exacerbation.
Key facts
- Who runs it
- The University of Texas Medical Branch, Galveston
- Where
- Galveston, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 20 people enrolled
- Started
- 30 Apr 2022
- Ended
- 10 Sept 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Application of compression to bilateral lower extremities of patients using appropriately-sized elastic compression stockings.
- Record updated
- 18 December 2024
- Why it stopped
- Due to lead student coordinator graduating.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Patients who are admitted with heart failure exacerbation with clinical evidence of volume overload in the form of lower extremity pitting edema
- Patients who are not yet recruited for other pharmacological or medical device clinical trials
Who cannot take part
- Severe peripheral artery disease
- Diagnosis of lower extremity deep venous thrombosis or pulmonary embolism in the last 3 months
- Age <18 years
- Patient on hemodialysis or peritoneal dialysis
- Simultaneous participation in another interventional study
- Impossibility to perform lower extremity compression, caused by pathology in either or both lower limbs (e.g. amputation, chronic wounds)
- No written informed consent
- Patient who are on invasive or non-invasive positive pressure ventilation (including BiPAP) or who are requiring >15L of oxygen
- Cardiogenic shock requiring catecholamine infusion
- Systolic blood pressure <80 mmHg
- Patients requiring mechanical circulatory support including intra-aortic balloon counter-pulsation or impella
- Patients on VAD (Ventricular Assist Device)
- Expected impossibility to obtain follow-up data at 12-week follow-up
- Pregnant women
Where in United States
- University of Texas Medical Branch (UTMB) GalvestonGalveston, United States
About the trial
What the trial wants to find out
Heart failure (HF) remains one of the most common causes of hospitalization with high morbidity and mortality, and its worldwide prevalence is increasing. Despite notable progress in outcomes for HF the rate of early rehospitalization for HF (re-HHF) remains high, especially in the first 30 days. The rate of 30-day HF rehospitalization in the claims databases of the USA and in worldwide randomized clinical trials is 20-25% and 5-10% respectively.
Read full original descriptionShow less
In patients with bilateral leg edema, the presence of CHF (congestive heart failure) as the factor causing or worsening local leg swelling should be evaluated. Application of local leg compression can be considered in stable CHF patients without decompensated heart function (NYHA Class I and II) for both CHF-related edema treatment and for treatment of concomitant diseases leading to leg swelling occurrence. Current literature does not have recommendations on the routine use of lower limb compression in leg swelling related to end stage heart disease and advanced, decompensated heart failure. Potential benefits of applying medical compression in more severe classes of CHF (NYHA Class III and IV) would need to be evaluated by further randomized clinical studies to determine which cohort of patients would benefit most from lower limb compression, as well as to choose the safest and most efficient compression protocol for these patients.
The AIM of this study is to improve the clinical outcome of patients admitted with exacerbation of heart failure with associated volume overload.
The primary objectives are: 1) diminish the duration of hospitalization of CHF patients; 2) decrease the incidence of rehospitalization from CHF exacerbation and 3) prevent local complications associated with prolonged lower extremity edema.
The investigators hypothesize that the application of local compression to bilateral lower extremities, when added to guideline-based therapy for CHF exacerbation, will improve overall clinical outcome in patients at the University of Texas Medical Branch (UTMB). If our intervention is proven to be beneficial, it could lead to a significant reduction in nationwide hospitalization costs associated with heart failure.
The 2 groups in the trial
- Interventional: Compression ArmTreatment being tested
Patients in the Compression group would be subject to application of standardized lower extremity, thigh-high, elastic compression stockings within 24 hours of admission. Appropriate size of the stockings would be based on calf circumference, thigh circumference and leg length. The compression would be applied throughout the entire duration of hospitalization, provided the patient is able to tolerate it. Daily thorough skin checks for any cutaneous defects or lesions will be performed, and mobilization encouraged.
Treatment: Application of compression to bilateral lower extremities of patients using appropriately-sized elastic compression stockings.
- Control ArmNo study treatment, for comparison
The inflatable sleeves of a sequential compression device would be placed in bilateral lower extremities of patients, but the device would not be turned on, thus no external pressure would be applied.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 December 2024